ReviewGlobal health & medicine2026
Integrating medical Mobility as a Service (MaaS) with the doctor-to-patient with nurse (D to P with N) telemedicine model and pharmacist-supported medication services: Towards mobility-integrated care for Japan's super-aged population.
Review in Global health & medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Japan has a super-aged society, where the population age 65 years or older accounted for 29.4% of the total population as of January 2026, and population aging, depopulation, and persistent physician shortages have increasingly constrained access to healthcare. These challenges are particularly evident in rural and remote areas, where mobility itself constitutes a major barrier to care. Although home medical care and telemedicine have been promoted as policy responses, each has inherent limitations when implemented independently. Against this backdrop, the practical integration of Mobility as a Service (MaaS) with the doctor-to-patient with nurse (D to P with N) telemedicine model has emerged as a policy-related approach to delivering multidisciplinary care under conditions of limited medical and transportation resources. In several municipalities in Japan, including early implementation sites such as the City of Ina, medical MaaS-based mobile healthcare initiatives have been implemented to reduce travel burdens while improving accessibility for patients with mobility challenges. From an implementation perspective, these initiatives demonstrate a growing convergence between medical MaaS and the D to P with N telemedicine model. Physicians provide remote consultations while nurses offer on-site clinical support, with telemedicine further linked to pharmacists' online medication counseling and medication delivery services. In practice, this integrated approach, which includes routine consultations, renewing prescriptions, and basic clinical monitoring, is primarily used for the stable management of chronic diseases and is mainly targeted at older patients receiving home-based care. By covering the care continuum from consultation to medication support, this approach aims to reduce patients' travel burden while ensuring the continuity of multidisciplinary care. Despite its potential, key challenges remain, including operational costs, data governance, and emergency response requirements. Overall, integrating medical MaaS with the D to P with N telemedicine model and pharmacist-supported medication delivery represents a significant step towards mobility-integrated care and may serve as a complementary component of community-based integrated care systems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.